Neurocrine Biosciences shares owned by Summit Investment Advisors
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Summit Investment Advisors
from 13F filings
Historical chart of Summit Investment Advisors investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Summit Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Summit Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $2.4M | 21k | 115.22 |
| 2024-06-30 | $2.9M | 21k | 137.67 |
| 2024-03-31 | $3.0M | 22k | 137.92 |
| 2023-12-31 | $2.9M | 22k | 131.76 |
| 2023-09-30 | $2.5M | 22k | 112.50 |
| 2023-06-30 | $2.3M | 24k | 94.30 |
| 2023-03-31 | $2.5M | 25k | 101.22 |
| 2022-12-31 | $2.7M | 25k | 108.75 |
| 2022-09-30 | $2.6M | 25k | 106.20 |
| 2022-06-30 | $2.5M | 25k | 97.46 |
| 2022-03-31 | $2.4M | 25k | 93.75 |
| 2021-12-31 | $2.2M | 25k | 85.16 |
| 2021-09-30 | $2.4M | 25k | 95.93 |
| 2021-06-30 | $2.5M | 26k | 97.32 |
| 2021-03-31 | $2.5M | 26k | 97.25 |
| 2016-03-31 | $263k | 6.7k | 39.48 |
| 2015-12-31 | $377k | 6.7k | 56.59 |
| 2015-09-30 | $262k | 6.6k | 39.75 |
| 2015-06-30 | $315k | 6.6k | 47.79 |
| 2015-03-31 | $296k | 7.4k | 39.76 |
More positions owned by Summit Investment Advisors
View all positions for Summit Investment Advisors